MedPath

Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients

Not Applicable
Conditions
Chronic Kidney Disease
Interventions
Behavioral: Education by DVD and dietician
Behavioral: education by DVD
Behavioral: Standard care
Registration Number
NCT01509027
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

Hyperphosphatemia is a common and severe complication in chronic kidney disease patients treated with hemodialysis. A phosphate restricted diet and oral phosphate binders are the cornerstones in the prevention and treatment of this complication. However, noncompliance is an prevalent problem resulting in poorly controled hyperphosphatemia in a substantial proportion of hemodialysis patients. The present study aims at identifying risk factors for non compliance and also test the hypothesis that compliance can be improved by education patients on the consequences of hyperphosphatemia and the importance of diet and phosphate binder therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • prevalent (>3months) hemodialysis patients
  • aged > 18 years
  • informed consent
Exclusion Criteria
  • decreased consciousness
  • unstable
  • medical contraindication for phosphorus restricted diet or phsophate binder therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Education by DVD and dieticianEducation by DVD and dieticianInformation on detrimental conseqences of hyperphosphatemia is presented on DVD and individual dietary counseling is given by dieticican
Education by unpersonalised DVDeducation by DVDInformation on detrimental consequences of hyperphosphatemia is presented on DVD
Standard CareStandard carestandard care
Primary Outcome Measures
NameTimeMethod
compliancebaseline and after intervention

impact of education (by DVD and interview with dietician)on compliance with phosphorus restricted diet and phosphate binder therapy

serum phosphate levelsbaseline and after intervention

impact of education (by DVD and interview with dietician) on serum phosphate levels

Secondary Outcome Measures
NameTimeMethod
risk factors of noncompliancebaseline

identification of risk factors for non compliance with emphasis on cognitive function and depression

Trial Locations

Locations (1)

University Hospitals Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath